Trial intelligence / Profile preview

Hypoglycemia Counterregulation with Insulin Detemir

NCT00490893Phase 4Terminated

Sponsor
University Hospital Tübingen
Start
Mar 2006
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

A Phase 4 trial of insulin detemir in diabetes mellitus (DM), sponsored by University Hospital Tübingen. Started Mar 2006; status: terminated.

02

Drugs

insulin detemir
03

Conditions

diabetes mellitus (DM)

Beyond the preview

Go deeper on NCT00490893.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00490893.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call